{# Drug is a Product subtype → Google requires offers. A generic spans many brands, so we expose the brand price range as an AggregateOffer. #}
🧬

Dapagliflozin Propanediol

Generic / Active Ingredient
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors 10 brands 7 manufacturers Tablet

What is Dapagliflozin Propanediol used for?

Type 2 DM

10 Dapagliflozin Propanediol brands in Bangladesh

Compare prices across every brand of Dapagliflozin Propanediol and pick the most affordable option.

Brand Strength Form Manufacturer Price
Dapaglip 5 mg Tablet Incepta Pharmaceuticals Ltd. ৳ 16.00
Dapaglip 10 mg Tablet Incepta Pharmaceuticals Ltd. ৳ 30.00
Daparol 5 mg Tablet Drug International Ltd. ৳ 12.00
Dapawin 5 mg Tablet Beacon Pharmaceuticals Ltd. ৳ 16.00
Dapazin 5 mg Tablet Concord Pharmaceuticals Ltd. ৳ 20.00
Dapazin 10 mg Tablet Concord Pharmaceuticals Ltd. ৳ 30.00
Diadap 5 mg Tablet Opsonin Pharma Ltd. ৳ 16.00
Dialozin 5 mg Tablet Jenphar Bangladesh Ltd. ৳ 16.00
Glycema 5 mg Tablet ACI Limited ৳ 16.00
Glycema 10 mg Tablet ACI Limited ৳ 30.00

Dapagliflozin Propanediol — Clinical Information

Indication DetailsView
Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Therapeutic ClassView
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
PharmacologyView
Dapagliflozin is a highly potent, selective, and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that improves glycemic control in patients with type 2 diabetes mellitus by reducing renal glucose reabsorption leading to urinary excretion of excess glucose (glucuresis).
DosageView
5 mg orally once a day. May increase to 10 mg orally once a day in patients tolerating therapy with 5 mg and requiring additional glycemic control
Side EffectsView
Renal impairment, Female genital mycotic infections, Urinary tract infection, Increased urination, Male genital mycotic infections, Dyslipidemia, Constipation, Discomfort with urination, Extremity pain, Volume depletion, Hypersensitivity
ContraindicationsView
Hypersensitivity to dapagliflozin propanediol or to any of the excipients. Moderate to severe renal impairment; end-stage renal disease; active bladder cancer. Pregnancy (2nd & 3rd trimester) & lactation.
PrecautionsView
CV disease, history of hypotension, UTI, Children, Elderly. Unknown whether distributed in human breast milk; breastfeeding women should discontinue dapagliflozin or nursing taking into account the importance of the drug to the mother
InteractionsView
Hypoglycemia may occur with concomitant use with insulin & insulin secretagogues eg sulfonylureas. Decrease in Cmax & AUC with rifampin. Increase in Cmax & AUC with mefenamic acid. Increased thiazide & loop diuretic effects; may increase risk of dehydration & hypotension. Pioglitazone.
Pregnancy & LactationView
Pregnancy Category-C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Pediatric UsageView
Renal Impairment: No dosage adjustment is indicated based on renal function. The efficacy is dependent on renal function. lt is not recommended for use in patients with moderate to severe renal impairment (patients with CrCI <60 mL/min or eGFR <60 mL/min/1.73 m2).